The Effect of Human Recombinant Erythropoietin (rHuEPO) and Tacrolimus (FK506) in Autologous and Homologous Full Thickness Skin Graft (FTSG) Take and Viability in a Rat Model
None
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2011
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/18938 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: The Effect of Human Recombinant Erythropoietin (rHuEPO) and Tacrolimus (FK506) in Autologous and Homologous Full Thickness Skin Graft (FTSG) Take and Viability in a Rat Model
- rhEPO for the Treatment of Erythropoietin Resistant Anemia in Hemodialysis Patients – Risks and Benefits
- Resistance to Recombinant Human Erythropoietin Therapy in Haemodialysis Patients
- Formulación nasal con actividad neuroprotectora empleando la rHu-EPO /
- fkcompute: an efficient $F_K$ invariant calculator
- The Protective Role of Erythropoietin in the Developing Brain
- Hyporesponsiveness to Erythropoietin-Stimulating Agents: Possible Solutions